Description:

ODM derived from http://clinicaltrials.gov/show/NCT00321620

Link:

http://clinicaltrials.gov/show/NCT00321620

Keywords:
Versions (4) ▾
  1. 3/20/12
  2. 3/20/12
  3. 4/14/14
  4. 4/20/14
Uploaded on:

April 20, 2014

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility DRKS00009676 NCT00321620 Bone Metastases

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Age 18 Years and older
Men >/= 18 years of age with histologically confirmed prostate cancer
Radiographic evidence of at least one bone metastasis
Failure of at least one hormonal therapy as evidenced by a rising PSA
Serum testosterone level of <50 ng/dL
ECOG performance 0,1 or 2
Adequate organ function
Exclusion Criteria
Current or prior IV bisphosphonate administration
Current or prior oral bisphosphonates for bone mets
life expectancy <6 months